Drug treatment of PD motor symptoms is centred around pharmacological dopamine substitution with levodopa still being considered the most efficacious agent, while dopamine agonists (DA agonists) have overall smaller effect size and greater risk of troublesome adversity including daytime sleepiness and impulse dyscontrol [6,7,8,9]
The protocol described below reflects general research dosing approaches and handling guidance using a multidose vial format common in preclinical or controlled laboratory settings
ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response
Material Safety Data Sheet (MSDS) Comprehensive Safety & Handling Guidelines
Integration with benchmark data of paired bulk and single-cell RNA sequencing data substantially improves the accuracy of bulk tissue deconvolution
Monthly costs range from $240-380 for TB-500 therapy, varying by dosage protocol and source quality